No companies went public this past week, during the post-Thanksgiving lull.
Three healthcare deals joined the IPO calendar for next week. Messenger RNA developer Moderna (MRNA) is the week's largest offering, aiming to raise $500 million in the biggest biotech IPO ever.
There were no new IPO filings, aside from two SPACs. Blank check company Andina Acquisition III (ANDAU) filed to raise $100 million to acquire a business in Latin America, while Chardan Healthcare Acquisition (CHACU) filed to raise $70 million as it explores a healthcare business to acquire. Therefore, what is currently in the IPO pipeline is what can go public in 2018; others will have to wait.
The IPO Index climbed 4.0% this past week, though it is still well below its level before the sell-off that began in October.
| 2 SPAC Filings During the Week of November 26th, 2018 | |||
|---|---|---|---|
| Issuer Business |
Deal Size |
Sector | Lead Underwriter |
| Andina Acquisition III (ANDAU) | $100M | SPAC | Cowen |
| Blank check company formed to acquire a business in Latin America. | |||
| Chardan Healthcare Acq. (CHACU) | $70M | SPAC | Chardan |
| Blank check company formed by Chardan to acquire a healthcare business. | |||
